Market Place
Sourcing Support
Disclosure of notification received from FMR LLC
26 Nov 2024 //
GLOBENEWSWIRE
Angels for Change Provides Project PROTECT Grant Update
14 Nov 2024 //
PR NEWSWIRE
Fagron Reports Outstanding Q3 2024 With 12.1% Revenue Growth
10 Oct 2024 //
GLOBENEWSWIRE
Solera Health Unveils New Brand Identity
09 Oct 2024 //
GLOBENEWSWIRE
Fagron’s share buy-back program: Weekly update
30 Aug 2024 //
GLOBENEWSWIRE
Fagron’s share buy-back program: Weekly update
23 Aug 2024 //
GLOBENEWSWIRE
Fagron Reports Strong H1 2024 Performance
01 Aug 2024 //
GLOBENEWSWIRE
Fagron shareholders approve all voting items at AGM and EGM
13 May 2024 //
GLOBENEWSWIRE
Disclosure notification from Mawer Investment Management Ltd.
19 Mar 2024 //
GLOBENEWSWIRE
Fagron publishes annual report 2023
14 Mar 2024 //
GLOBENEWSWIRE
Fagron delivers strong performance with 12% topline growth
15 Feb 2024 //
GLOBENEWSWIRE
Disclosure notification from AOC Pharma S.Ã r.l. passing 10% threshold
08 Jan 2024 //
GLOBENEWSWIRE
Enforcement Report - Week of December 27, 2023
27 Dec 2023 //
FDA
Disclosure of notification received from BNP Paribas Asset Management SA
11 Dec 2023 //
GLOBENEWSWIRE
Continued strong Q3 performance with 11% topline growth to ‚¬191 million
12 Oct 2023 //
GLOBENEWSWIRE
Fagron completes share buy-back program
19 Sep 2023 //
GLOBENEWSWIRE
Progress share buy-back program Fagron
15 Sep 2023 //
GLOBENEWSWIRE
Progress share buy-back program Fagron
08 Sep 2023 //
GLOBENEWSWIRE
Progress share buy-back program Fagron
01 Sep 2023 //
GLOBENEWSWIRE
Progress share buy-back program Fagron
25 Aug 2023 //
GLOBENEWSWIRE
Progress share buy-back program Fagron
18 Aug 2023 //
GLOBENEWSWIRE
Fagron delivers strong performance with 13% growth and 14% increase in REBITDA
03 Aug 2023 //
GLOBENEWSWIRE
Fagron delivers strong performance with 13% growth & 14% increase in REBITDA
03 Aug 2023 //
GLOBENEWSWIRE
Fagron shareholders approve majority voting items
08 May 2023 //
GLOBENEWSWIRE
Strong first quarter performance with 16% topline growth to €181 million
13 Apr 2023 //
GLOBENEWSWIRE
Fagron publishes agenda for annual shareholders meeting
07 Apr 2023 //
GLOBENEWSWIRE
Fagron publishes annual report 2022
20 Mar 2023 //
GLOBENEWSWIRE
Fagron reports 19% topline growth, 11% increase in REBITDA
09 Feb 2023 //
GLOBENEWSWIRE
Disclosure of notifications received from Active Ownership Corporation S.Ã r.l.
19 Dec 2022 //
GLOBENEWSWIRE
Fagron delivers topline growth of 21.5% to €173 million
13 Oct 2022 //
GLOBENEWSWIRE
Fagron commits to set science-based emission reduction targets
26 Sep 2022 //
GLOBENEWSWIRE
Fagron expands its US sterile compounding footprint with East coast acquisition
05 Jul 2022 //
GLOBENEWSWIRE
Fagron Group B.V. Receives FDA Warning Letter
29 Jun 2022 //
FDA
Fagron increases share capital through exercise subscription rights
13 Jun 2022 //
GLOBENEWSWIRE
Enforcement Report - Week of May 18, 2022
19 May 2022 //
FDA
Fagron Sterile Services US Launches RFID enabled products
12 May 2022 //
PRNEWSWIRE
Fagron shareholders approve all voting items AGM and EGM
09 May 2022 //
GLOBENEWSWIRE
Fagron Inc. Issues Voluntary Nationwide Recall of SyrSpend SF Cherry
02 May 2022 //
FDA
Fagron Issues Voluntary Nationwide Recall of SyrSpend SF Cherry
29 Apr 2022 //
PRNEWSWIRE
Fagron reports 16% increase in revenue to $156.4 million
14 Apr 2022 //
GLOBENEWSWIRE
Fagron publishes agenda 2022 annual and extraordinary general meeting
08 Apr 2022 //
GLOBENEWSWIRE
Fagron to present medium-term strategic objectives at its Capital Markets Day
14 Mar 2022 //
GLOBENEWSWIRE
Disclosure of received notification of Kabouter Management LLC
17 Feb 2022 //
GLOBENEWSWIRE
Pharma Nobis Acquires Fagron’s Contract Manufacturing Business and Facility
04 Feb 2022 //
BUSINESSWIRE
Fagron strengthens position in US with acquisition of Letco
01 Feb 2022 //
GLOBENEWSWIRE
Changes to Fagron’s Board of Directors
03 Dec 2021 //
PRESS RELEASE
Enforcement Report - Week of December 11, 2019
11 Dec 2019 //
FDA
Fagron to pay $22.5 million to settle U.S. allegations over inflated drug prices
09 Nov 2019 //
REUTERS
Enforcement Report - Week of July 11, 2018
11 Jul 2018 //
FDA
Fagron Issues Voluntary Nationwide Recall of Neostigmine Methylsulfate
05 Jul 2018 //
FDA
Enforcement Report - Week of March 7, 2018
07 Mar 2018 //
FDA
Fagron,Extends Pharma Ingredient Supply Chain To American Pharma Ingredients`
01 Feb 2018 //
PR NEWSWIRE
Enforcement Report - Week of November 22, 2017
22 Nov 2017 //
FDA
Enforcement Report - Week of July 12, 2017
12 Jul 2017 //
FDA
Fagron and Advanced Pharma pull drugs made at Pfizer`s Rocky Mount site
27 Jun 2017 //
IN PHARMATECHNOLOGIST
Enforcement Report - Week of May 10, 2017
10 May 2017 //
FDA
